Iradimed (IRMD) Free Cash Flow Growth (3y) (2016 - 2026)
Iradimed (IRMD) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 9.23% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 20.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.26% |
| Mar 31, 2026 | 20.70% |
| Dec 31, 2025 | 26.50% |
| Sep 30, 2025 | 16.01% |
| Jun 30, 2025 | 52.16% |
| Mar 31, 2025 | -21.77% |
| Dec 31, 2024 | -2.96% |
| Sep 30, 2024 | 19.78% |
| Jun 30, 2024 | 15.72% |
| Mar 31, 2024 | 59.75% |
| Dec 31, 2023 | 56.96% |
| Sep 30, 2023 | -0.69% |
| Jun 30, 2023 | -76.57% |
| Mar 31, 2023 | 63.29% |
| Dec 31, 2022 | -10.60% |
| Sep 30, 2022 | 5.42% |
| Jun 30, 2022 | -15.11% |
| Mar 31, 2022 | 23.77% |
| Dec 31, 2021 | 0.32% |
| Sep 30, 2021 | 74.22% |